MINDRAY BIO-MEDICAL (300760.SZ) , a mainland China-based medical equipment manufacturer listed on the A-shares market, is considering a secondary IPO in Hong Kong, aiming to raise at least USD1 billion (approximately HKD7.8 billion), Bloomberg, citing people with the knowledge of the matter, reported.

The company has engaged in discussions with potential advisors regarding the possible share offering.

Based on the closing price yesterday (22nd), the company's market cap was RMB274.012 billion, making it one of the largest mainland-listed companies seeking a secondary listing in Hong Kong.
(A Shares quote is delayed for at least 15 mins.)